Suchergebnisse - "Knapper, Steven"

PubPharm (9)

1

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Russell, N. | Wilhelm-Benartzi, C. | Othman, J. | +117

2

Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML : the UK NCRI AML18 trial

enthalten in: Blood | 2023

von Freeman, S. | Thomas, A. | Thomas, I. | +19

CommentIn: Blood. 2023 Nov 16;142(20):1673-1674. - PMID 37971761

3

A randomised evaluation of low-dose Ara-C plus pegylated recombinant arginase BCT-100 versus low dose Ara-C in older unfit patients with acute myeloid leukaemia : Results from the LI-1 trial

enthalten in: British journal of haematology | 2023

von Mussai, F. | De Santo, C. | Cheng, P. | +13

4

Randomized evaluation of quizartinib and low-dose ara-C vs low-dose ara-C in older acute myeloid leukemia patients

enthalten in: Blood advances | 2021

von Dennis, M. | Thomas, I. | Ariti, C. | +11

5

The targeted histone deacetylase inhibitor tefinostat (CHR-2845) shows selective in vitro efficacy in monocytoid-lineage leukaemias

enthalten in: Oncotarget | 2016

von Zabkiewicz, J. | Gilmour, M. | Hills, R. | +5

6

Elacytarabine in relapsed/refractory acute myeloid leukaemia : an evaluation of clinical efficacy, pharmacokinetics, cardiac safety and effects on lipid profile

enthalten in: Leukemia research | 2014

von Knapper, S. | Chevassut, T. | Duarte, R. | +8

7

Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival

enthalten in: Blood | 2013

von Burnett, A. | Russell, N. | Hunter, A. | +9

8

The HSP90 inhibitor NVP-AUY922-AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells

enthalten in: British journal of haematology | 2013

von Walsby, E. | Lazenby, M. | Pepper, C. | +2

9

The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine

enthalten in: Haematologica | 2011

von Walsby, E. | Coles, S. | Knapper, S. | +1

1
[1]